影响宫癌患者生存的因素
Mohammadreza Balooch Hasankhani1, Yunes Jahani1,2, Azam Bazrafshan3
1Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Iranian journal of public health
|October 30, 2023
概括
宫癌的生存率受到诊断年龄,BMI和疾病阶段的影响. 与手术相比,先进的阶段和放射治疗/化疗等治疗方法会增加死亡风险.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 生物统计学 生物统计学
背景情况:
- 宫癌是全球重要的健康问题,是女性癌症相关死亡的第四大原因.
- 确定预后因素对于改善宫癌患者的生存率和指导治疗策略至关重要.
研究的目的:
- 调查影响宫癌患者生存结果的关键因素.
- 提供数据,可以为预防癌症进展和提高治疗疗效的策略提供信息.
主要方法:
- 这是一项回顾性队列研究,涉及2012年至2022年期间注册的254名宫癌患者.
- 利用扩展的考克斯模型来分析影响患者存活时间的变量,并考虑治疗类型.
- 数据来源于克尔曼基于人口的癌症注册表 (KPBCR).
主要成果:
- 平均存活时间为91.28±3.02个月.
- 诊断时的年龄增加 (HR=1.02) 和更高的身体质量指数 (BMI) (HR=0.93) 与死亡风险增加有关.
- 晚期疾病阶段 (III和IV) 与早期阶段 (I和II) 相比,死亡风险增加了3.08倍.
- 接受放射治疗和/或化疗的患者比接受手术的患者死亡风险高7.11倍.
结论:
- 诊断时的年龄,BMI,疾病阶段和治疗方式是宫癌患者生存的重要决定因素.
- 强调定期查和早期诊断对于降低死亡率和预防宫癌进展至关重要.
相关概念视频
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Assumptions of Survival Analysis
136
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
136
Comparing the Survival Analysis of Two or More Groups
201
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
201
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Factors Affecting the Risk of Infection
11.9K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


